Sernova Biotherapeutics Inc (FRA:PSH0)
0.1060
-0.0130 (-10.92%)
Last updated: Aug 12, 2025
Sernova Biotherapeutics Market Cap
Sernova Biotherapeutics has a market cap or net worth of €39.84 million as of August 14, 2025. Its market cap has decreased by -27.13% in one year.
Market Cap
39.84M
Enterprise Value
41.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.11
Market Cap Chart
Since June 29, 2000, Sernova Biotherapeutics's market cap has increased from 12.10M to 39.84M, an increase of 229.24%. That is a compound annual growth rate of 4.85%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 14, 2025 | 39.84M | -19.70% |
Dec 31, 2024 | 49.62M | -67.75% |
Dec 29, 2023 | 153.86M | -3.89% |
Dec 30, 2022 | 160.10M | -51.52% |
Dec 31, 2021 | 330.23M | 266.42% |
Dec 31, 2020 | 90.12M | 293.80% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 270.19B |
Siemens Aktiengesellschaft | 179.70B |
Deutsche Telekom AG | 147.51B |
Allianz SE | 138.79B |
Siemens Energy AG | 81.94B |
Rheinmetall AG | 71.61B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.49B |
Deutsche Bank Aktiengesellschaft | 59.56B |